{"organizations": [], "uuid": "2af98726c633a55151f1044544a9673c26e2fd55", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/endo-intl-results/generic-drugmaker-endos-loss-narrows-as-impairment-charges-drop-idUSL4N1QH4K0", "country": "US", "domain_rank": 408, "title": "Generic drugmaker Endo's loss narrows as impairment charges drop", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.01, "site_type": "news", "published": "2018-02-27T19:14:00.000+02:00", "replies_count": 0, "uuid": "2af98726c633a55151f1044544a9673c26e2fd55"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/endo-intl-results/generic-drugmaker-endos-loss-narrows-as-impairment-charges-drop-idUSL4N1QH4K0", "ord_in_thread": 0, "title": "Generic drugmaker Endo's loss narrows as impairment charges drop", "locations": [], "entities": {"persons": [{"name": "endo", "sentiment": "negative"}, {"name": "savio", "sentiment": "none"}, {"name": "akankshita mukhopadhyay", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}, {"name": "dublin", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "endo international plc", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 14 AM / Updated 8 minutes ago Generic drugmaker Endo's loss narrows as impairment charges drop Reuters Staff 1 Min Read Feb 27 (Reuters) - Generic drugmaker Endo International Plc reported a smaller fourth-quarter loss on Tuesday, due to lower asset impairment charges. Net loss attributable to shareholders narrowed to $368.4 million, or $1.65 per share, in the quarter ended Dec. 31, from $3.34 billion, or $14.98 per share, a year earlier. The Dublin, Ireland-based company recorded asset impairment charges of $130.45 million in the latest quarter, much less than the $3.52 billion charges it took a year ago. Total revenue fell to $768.6 million from $1.24 billion. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Savio Dâ€˜Souza)", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T19:14:00.000+02:00", "crawled": "2018-02-27T13:26:41.037+02:00", "highlightTitle": ""}